Becton, Dickinson company profile
Company profile
Becton, Dickinson has 60,000 employees and is headquartered in Franklin Lakes, United States.
Hospitals, clinics, physicians, pharmaceutical companies, clinical laboratories and life science researchers form the core customer base of this medical technology group, which also sells to the general public in markets across the world. Its offering ranges from intravenous catheters, vascular access devices, syringes and needles to drug delivery and infusion systems, pharmacy automation software and hemodynamic monitoring. The company also supplies blood collection products, microbiology and molecular testing instruments, flow cytometry equipment, and surgical products such as hernia and soft tissue repair solutions and biosurgery grafts. Its operations are organized in the Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments.
Revenue reached 21.8 billion US dollars in the fiscal year ended September 2025, up 8.2% from the previous year, and net income was 1.7 billion dollars. By region, the United States accounted for 58.6% of revenue, EMEA for 21.7%, Asia for 14.2% and other countries for 5.6%. The company has a strategic collaboration with ChemoGLO on hazardous drug contamination testing in health care settings. It employs 60,000 people and is headquartered in Franklin Lakes, New Jersey, where it was founded in 1897.
Company facts
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Headquarters
- 1 Becton Drive, 07417-1880, Franklin Lakes
- Employees
- 60,000
- Chief executive
- Thomas Polen
- Founded
- 1897
- Fiscal year
- October - September
- Listing
- BDX · NYSE
- Indices
- S&P 500
- Currency
- USD
- ISIN
- US0758871091
- Website
- bd.com
Becton, Dickinson and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| Becton, DickinsonBDX | United States | $59.39B | 60,000 | 15.7% | 43.1 |
| MedlineMDLN | United States | $51.94B | 45,000 | 5.4% | 89.7 |
| ResMedRMD | United States | $33.69B | 11,370 | 34.0% | 21.8 |
| West Pharmaceutical ServicesWST | United States | $29.01B | 10,000 | 22.9% | 46.7 |
| Intuitive SurgicalISRG | United States | $153.77B | 17,021 | 31.7% | 53.6 |
| SolventumSOLV | United States | $15.14B | 20,584 | 5.9% | 100.1 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
